
Nick Norwitz MD PhD
@nicknorwitz • 123,564 subscribers
MD, PhD. Harvard, Oxford. Educator. Professional Guinea Pig. StayCurious Metabolism Letter, Top Best-Seller in Science 🔗 https://t.co/YoPdkV719L
Shorts
Videos

🚨#OreoVsStatin - PUBLISHED!🚨 OREO Cookie cookies were 💥2X as potent💥 at lowering my LDL cholesterol (LDL-C) compared to high-intensity statin therapy! What you NEED to know... 👉This was a metabolic demonstration, a 'do not do this at home' experiment that makes no 'health' claims about cookies or cholesterol. 👉The purpose was to BOLDLY test a prediction of the Lipid Energy Model #LEM, i.e. that adding in carbs, including in the from of an Oreo cookies 'addition' (not carb-fat swap) would lower LDL-C in an LMHR on a #keto diet Why Oreos? ... It's (productively) provocative! 😱 Research on #cholesterol on #keto diets and the #LEM and #LMHR phenotype has so much to teach us about human lipid metabolism! ... But how do I (we) communicate the scientific 'awe' that we feel to the greatest number of people (as well as force a conversation about #LMHR and #LEM that needs to happen)? ... A dramatic demonstration designed to turn heads might work! It's not 'just click bait' ... it's 'legit-bait' I want YOU to feel the 'shock and awe' I feel every day studying this topic. And I want you to engage in the research journey. What you need to do... or should do... 🙏PRETTY PLEASE 🙏! 👉PLEASE WATCH 👀 VIDEO ABSTRACT here (<8 min): 👉 SHARE THIS LINK to the paper itself in a quote RT or original Tweet of your own: ... doing so helps promote the work and provoke the discussion ... and feel free to tag in your favorite influencers (or least favorite 😉)... A HUGE thanks to the senior author and expert lipidologist William Cromwell, MD for his guiding wisdom, insightful thoughts, and always open and curious mind. And to Dave Feldman, my friend, research wife, and the '#LEM daddy' Finally... there will be a LOT of coverage of this experiment. Keep in mind, we are not making any health claims, but through a dramatic demonstration, highlighting an uncomfortable tension that arises from a prediction of the Lipid Energy Model, and that is consistent with prior data (7+ papers, including 'highest tier' data like our recent meta-analysis of 41 RCTs). Science is supposed to embrace such uncomfortable questions... so, join us in being curious and advocating for much needed research on #LEM and #LMHR so we can make sense of what observations like this really mean... STAY CURIOUS 🤔
Nick Norwitz MD PhD3,217,104 次观看 • 2 年前

If you have high Lp(a), like me, here are 5 things you need to know to protect your heart: 1. Lp(a) is ~90% genetic. While it can be influenced at the margins (e.g. inflammation), most people have a genetic “floor.” I inherited mine from my father. Do you know yours? 2. Your genes may be fixed—but your jeans aren’t. Specifically, visceral fat matters. People with low waist-to-hip ratios, a proxy for less visceral fat, often show little to no added cardiovascular risk from high Lp(a). Why? Because Lp(a) interacts with the metabolic environment. 3. Medications matter. Statins can increase Lp(a), while PCSK9 inhibitors tend to decrease it. 4. Vitamin C may help reduce the atherogenicity of Lp(a) by working inside the lumen of blood vessels and inside artery walls 5. Ketogenic diets may also reduce Lp(a)-related risk—working inside the artery to lower inflammation, oxidative stress, and depletion of key cofactors caused by Lp(a). This is the Cliff Notes version. For the full deep dives—10,000+ words of nuance, mechanisms, and references—check the comments and stay curious.
Nick Norwitz MD PhD111,286 次观看 • 2 个月前

Gene Editing For LDL Lowering in 5 minutes 👇 I’d appreciate if those interested in the new VERVE-102 / PCSK9 Gene Editing for Cholesterol research take 5 minutes to hear me out on why this is a breakthrough. People are missing key details and the bigger story. Cc Dave Feldman Austin Dudzinski, PharmD, BCACP Abud Bakri MD NEJM Dr. David Ludwig Dr David Unwin Louisa Nicola Hundred Health Darius Sharpe Dr Shawn Baker 🥩 Jan Ellison Baszucki Bret Scher, MD Benjamin Bikman Eric Rodgers
Nick Norwitz MD PhD13,295 次观看 • 8 天前

Cardiology has become obsessed with the mantra “lower is better.” Lower LDL, lower ApoB, and you're going to be better off. This simple tagline misses the forest for a stupid little cholesterol shrub. It’s well known that intervening to lower LDL and ApoB doesn’t necessarily result in better overall outcomes for the whole person, even in circumstances where cardiovascular risk might be reduced. It's therefore incredibly sad when "certain cardiologist experts" (heavy quotes there) make false claims like: "people with a PCSK9 loss of function mutation have very low LDL-C and live 15-20 years longer than those who don't. And we have meds now that cause that effect." That nonsense I could forgive. What is far more troubling is that there's a general failure to challange problematic (and sometimes outright false) narratives like this provided they align with the status quo, even when the status quo has failed public health miserably. We need to broaden the aperture of the discussion because the "science is not settled." Below is an excerpt from this morning video on the lipid marker linked to longevity (not LDL or ApoB): 🚨Then, of course, watch The Cholesterol Code movie on Amazon and leave a review! #CholesterolCodeMovie Dave Feldman
Nick Norwitz MD PhD55,569 次观看 • 1 个月前

🔥 Why I’m Committed to Making Metabolic Health Mainstream (in 2 min) 🔥 From a young age, I was fascinated by the wonders of biology, but it was a personal health crisis that truly defined my mission: to Make Metabolic Health Mainstream. After battling severe inflammatory bowel disease and finding remission through a metabolic health intervention, I knew I had found my purpose. Now, I'm on a mission to inspire change, spark conversation, and shift the way we think about health at its core. But I can’t do it alone... I need an army of Metabolic Health Enthusiasts —people who are ready to go beyond investing in their own health to help change the culture, disrupt norms, and provoke hard but necessary discussions Watch this 2-minute video, and if my story resonates with you, I invite you to join me on this journey. ⁉️Ask Hard Questions, Authentically 🫂Support Your Fellow Metabolic Health Enthusiasts 🤔Engage. Give Feedback! 🗣️Share this message and share your story! Together, we can make Metabolic Health a Movement that transforms lives. #MetabolicHealth #StayCurious
Nick Norwitz MD PhD443,000 次观看 • 1 年前

🚨This is crazy—and you haven’t seen it. A Stanford randomized controlled trial found that high-dose of a specific soluble fiber increased liver injury markers (ALT) in some people. The trial was stopped early for safety in a subset of participants. Let your brain ferment that. For more fiber nuance, check out today's interview with Dr. Andrew Koutnik, Ph.D. ... if you're brain is constipated, he's like heavy dose ex-lax
Nick Norwitz MD PhD133,024 次观看 • 5 个月前

Calories don’t cause obesity any more than an odometer causes driving. The persistence of the CICO mindset isn’t due to rigorous intellectual debate among competing models — it’s due to confusion. CICO isn’t a model of obesity. It’s a circular thinking masquerading as science.
Nick Norwitz MD PhD138,326 次观看 • 7 个月前

Statins Slash GLP-1: (~10-minute Data Digest for X) Human trial data published in a major journal show that statins cause insulin resistance and deplete GLP-1 levels in humans. This should have been breaking news... But no one talked about it. Why don’t doctors know? Why aren’t patients being informed about the risks? PLEASE really listen to what I’m saying and why I’m upset. It’s more nuanced than scaremongering about medications or economic conspiracy theories. 🔁If you care, share (retweet and tag your favorite, or least favorite, health influencer) 🔗Links to the YouTube video, Substack article, and Instagram posts in first comment. - Cell Metabolism (PMID: 38325336)
Nick Norwitz MD PhD168,388 次观看 • 9 个月前

This is—without a doubt—the longest I’ve ever sat on a video before releasing it. Because once I open this Pandora’s box, there’s no closing it. 🚨Full Video: In this video, I share my personal decision to walk around with an LDL of 574 mg/dl and a total cholesterol over 700. But this isn’t about one biomarker, or one study. Decisions about whether to act, when to act, and how to act aren’t simple math problems. Individual complexity and thoughtful consideration can turn what looks like a straightforward equation into something far more nuanced. 🚨This video isn’t about telling you what to think—it’s about showing you how I think. It’s not about dogma or conspiracy. It’s about authenticity, transparency, and the kind of nuanced conversations we need to have if we’re going to approach this topic responsibly. And I say that without irony. If you watch all the way through—rather than jumping to conclusions—you might be surprised by where I land… and what I’m planning next. We don't need to agree. We do need to be willing to keep our eyes, ears, and hearts open to new data and divergent opinions. cc Dave Feldman Adrian Soto-Mota Bret Scher, MD Dr Aseem Malhotra Jan Ellison Baszucki Metabolic Mind Coalition for Metabolic Health Austin Dudzinski, PharmD, BCACP Eric Rodgers Andrew Koutnik, Ph.D. Peter Attia (I'm sure we'll have a productive and cordial chat one day)
Nick Norwitz MD PhD138,478 次观看 • 7 个月前

Cardiology Has an LDL Obsession. What to Measure Instead... 🔗New video: 👇1 min clip on LDL vs Insulin Resistance The landscape of atherosclerosis is changing. New drugs are lowering LDL, total cholesterol and ApoB lower and lower, while larger risk factors like insulin resistance, obesity, and diabetes persist. If you want a comparison, lipoprotein insulin resistance score (LP-IR). Because 1.0 is risk neutral, insulin resistance score is a more than 14X more powerful predictor of new coronary heart disease than LDL. But we know who gets all the attention. Answer: [See Clip] That’s not proportional medicine Do you agree? For more nuances see the video linked above. cc Benjamin Bikman Dave Feldman
Nick Norwitz MD PhD77,831 次观看 • 4 个月前

🚀Did your #LDL cholesterol sky-rocket on #keto? 🧈Were you told it' was because of Saturated Fat? 🚨NEW META OF 41 RCTs just busted that MYTH! 3 Main findings 👉 In studies with 'lean' BMI ( 35), LDL-C ⬇️ 💥BOOM, there's a money shot!💥 👉 Inverse association between BMI and LDL-C 👉 BMI dominates over saturated fat, which has comparatively minimal impact; thus, it's more likely having 6-pack abs is a severe risk factor for high LDL-C on #keto, not butter, beef, bacon or cream 🔗PAPER LINK 🔗 - (To share the data love, copy this link to a Quote tweet or original Tweet with your reaction. Please engage!) FULL Video Abstract (7 min): Major props to first-author Adrian Soto-Mota and senior Dr. David Ludwig. These man are humble & kind geniuses that I'm privileged to know and learn under And +100 pts for the #LEM ⚡️ Dave Feldman Of interest to More Plates More Dates Peter Attia @PlantChompers and Walter Willett (if he had a Twitter) Simon Hill MSc, BSc Thomas Dayspring William Cromwell, MD LipoFan Andrew D. Huberman, Ph.D. Dominic D'Agostino Layne Norton, PhD Metabolic Health Summit
Nick Norwitz MD PhD269,263 次观看 • 2 年前

Fiber ≠ fiber. Some fibers (e.g. arabinoxylan) lower cholesterol on average. Others (like inulin) often don’t. And at the individual level? Some people actually see LDL go up with inulin. The question isn’t “Is fiber good or bad?” It’s which fiber, at what dose, in whom. Details + mechanisms in the deep dive linked at the end of the associated thread. #StayCurious
Nick Norwitz MD PhD60,388 次观看 • 5 个月前

LDL and the Problem of Incomplete Framing 🫀 Here's my mini rant... There is long list of risk factors that carry far greater consequence than LDL alone. Take obesity, type 2 diabetes, insulin resistance, elevated blood pressure, chronic inflammation, smoking history. I could go on, but the point is actually really obvious... When LDL cholesterol monopolizes the spotlight, the problem is that the framing is incomplete. Instead, it becomes actively harmful to patients to pull away attention and clinical urgency from factors that matter more than LDL. The spotlight of medicine directs attention and resources, towards what's easiest to monetize and medicalize: LDL cholesterol, a marker that's easy to smash with a drug that makes money. I am NOT making the argument about bad intentions. I'm describing a clear systemic problem, one that perpetuates the broader metabolic health epidemic we continue to find ourselves in, including cardiovascular disease.
Nick Norwitz MD PhD45,303 次观看 • 4 个月前

My Cholesterol Is Over 700... But My Arteries Are Clean If you take literally *64 sec* to watch this short, you’ll realize: this isn’t a flex. It’s a reminder that medicine lives in the gray, and that blindly repeating platitudes like “lower cholesterol is always better” fails real patients. We need more research. More personalization. More curiosity — and less dogma. Do you agree? 👍 👎
Nick Norwitz MD PhD50,934 次观看 • 6 个月前